DANAPHA PHARMACEUTICAL JOINT STOCK COMPANY
VN
Lieferantenbewertung
Kontaktdetails
Produktkategorien
Goldenen stern salbe& liniment
Why Choose Us
Danapha Pharmaceutical Joint Stock Company is one of the first pharmaceutical companies in Viet Nam received the Good Manufacturing Practices Certificates as recommended by the World Health Organization.
We are leading in Vietnam as a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm, medicated oil.
Modern factory of Danapha has reached international standards with innovative modern equipments as well as high techniques in manufacturing, researching and quality controlling.
Products of Danapha have been distributed nationwide as well as exported to Eastern Europe as Russia, SNG countries, Cuba, Thailand, Myanmar and Laos. We are planning to enter Nigeria, Africa, USA and EU markets.
With the mission Improve Quality of Human Life, we develop and produce innovative, high-quality pharmaceutical products and service aimed at improving quality of life for people with healthcare needs.
Developing the quintessence of Oriental traditional medicine by applying modern technologies is one of our long-term targets. We have cooperated with partner to transfer and achieve technologies and searched distributors in over the world to get good business on the spirit All for STABLE COOPERATION and SATISFY ALL DEMANDS OF PARTNERS and DISTRIBUTORS.
We are looking forward to having cooperation with you.
Please visit our website www.danapha.com and contact with us:
Ms. Hoang Giang Nguyen
Trading Promotion Manager
Tel & Fax: 84.511.3713087
Founded in 1965
101 - 200 People
5,000-10,000 square meters
VORSTELLUNG DES UNTERNEHMENS
Art der Verifizierung:
Land/Region:
Da Nang, Vietnam
Jahr der Firmengründung:
1965
Unternehmenstyp:
Hersteller, Handelsgesellschaft
Hauptprodukte:
Medizin, Kräutermedizin, Balsam, Inhalator, heilkräftiges Öl, Einspritzung, Tablette, Kapsel, neue Droge, Antidiabetika,
Hauptmärkte:
Nordamerika, Südamerika, Osteuropa, Südostasien, Afrika
Gesamtzahl der Beschäftigten:
101 - 200 People
Contact Supplier
Learn more about us >
Kernkompetenz des Unternehmens
R&D Capability
Anzahl der F & E-Mitarbeiter:
11 - 20 People
Production Capability
Production Lines:
Above 10
OEM Capability
OEM Experience:
0 years
Quality Control
QC Staff:
21 - 30 People
Hauptmärkte
Nordamerika
Südamerika
Osteuropa
Südostasien
Afrika
nachricht senden, lieferant
Messeage gesendet wurde erfolgreich.
überprüfen sie ihre messeages auf